Formulation Development
Novel Small Molecule Drug Discovery Platform Harnesses Immune System to Defeat Cancers, Viral Infections & Inflammatory Diseases
Now, the power of nucleic acid technology is being harnessed to design small molecule nucleic acid hybrid (SMNH) drugs that harness the patient’s own immune system to defeat…..
Rafael Pharmaceuticals Announces Expansion Into France of Pivotal Phase 3 Trial
Rafael Pharmaceuticals, Inc. recently announced the expansion of its Phase 3 clinical trial for patients with metastatic pancreatic cancer (AVENGER 500) into France. AVENGER 500…
Wave Life Sciences Announces Fast Track Designation from US FDA
Wave Life Sciences Ltd. recently announced the US FDA has granted Fast Track designation to suvodirsen for the treatment of Duchenne muscular dystrophy (DMD) in…
Ovid Therapeutics Announces First Patient Randomized in Pivotal Phase 3 Trial
Ovid Therapeutics Inc. recently announced the first patient has been randomized in the company’s single, pivotal Phase 3 NEPTUNE clinical trial evaluating OV101 (gaboxadol), a…
Cellectar Presents Data From Phase 1 Study
Cellectar Biosciences, Inc. recently announced Mr. Jarrod Longcor, chief business officer of Cellectar presented data from Cohort 6 of its Phase 1 dose escalation study…
Allena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial
Allena Pharmaceuticals, Inc. recently announced it has completed enrollment in its pivotal Phase 3 URIROX-1 clinical trial. URIROX-1 is a multi-center, global, randomized, double-blind, placebo-controlled…
Oramed Announces Last Patient Treated in Pivotal Oral Insulin Trial
Oramed Pharmaceuticals Inc. recently announced the treatment of the last patient in the primary cohort of the Phase 2b HbA1c trial evaluating Oramed's lead oral…
TYME Presents Positive Circulating Tumor Cell Data
Tyme Technologies, Inc. recently reported encouraging data on circulating tumor cells (CTCs) and a correlation with decrease in risk of death using TYME's lead candidate,…
Kitov Pharma Presents Newly Released Data for Reversing Pancreatic Cancer Drug Resistance
Kitov Pharma Ltd. recently presented newly released proof-of-concept data showing evidence of NT-219 mechanism of action in reversing cancer drug resistance in PDX models. The…
Toronto Innovation Acceleration Partners Announces Strategic Partnership With Amgen
Toronto Innovation Acceleration Partners (TIAP – formerly MaRS Innovation), a leading member-based Canadian provider of venture builder expertise in the early stage health science field,…
ORYZON’s Ladademstat Shows Efficacy Signs in Relapsed SCLC
Oryzon Genomics, S.A. recently presented the first preliminary data from CLEPSIDRA, a Phase 2 trial investigating iadademstat in combination with standard-of-care in relapsing small cell…
ProBioGen Licenses Technology to Bayer
ProBioGen AG, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, recently announced the closing of a license agreement with Bayer AG…
Flexion Therapeutics & Xenon Pharmaceuticals Announce Acquisition
Flexion Therapeutics, Inc. and Xenon Pharmaceuticals Inc. recently announced the companies have entered into a definitive agreement that provides Flexion with the global rights to…
Novartis Investigational Lung Cancer Therapy Granted FDA Breakthrough Therapy Designation
"We are pleased to announce that the US FDA granted Breakthrough Therapy Designation to capmatinib (INC280) as a first-line treatment for patients with metastatic MET…
Nabriva Therapeutics Earns $5-Million Milestone Payment
Nabriva Therapeutics plc recently announced that Nabriva has earned a $5-million milestone payment under its licensing agreement with Sinovant Sciences related to the U.S. regulatory…
2019 Analytical Testing in Drug Development eBook - Regulations Help Propel Testing Market
This e-Book showcases the various types of services that leading testing companies offer and how they are helping industry comply with regulations to get their products approved and commercialized.
Catalent to Open New Clinical Supply Facility in San Diego
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, recently announced it…
Accenture Announces Collaboration With Bayer
Accenture recently announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its……
Sanofi & Abbott Partner, Changing the Way Diabetes is Managed
Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes……
AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial
AC Immune SA recently announced it has received a milestone payment from its partner Life Molecular Imaging in connection with the initiation of….
